RxDoctor Payments Data

Jeffrey Dull, DPM

Podiatrist · Bay Minette, ALNPI 1275560344

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (52.5%), travel and lodging and gifts — rather than concentrated in one kind of arrangement. Stryker accounts for 60.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $1,426 and has fallen 65.6% since, to $490 in 2025.

$4,271in general payments, 2019–2025

Across 51 payments — averaging $83.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3K
  • Voom Medical Devices, Inc.$957
  • Organogenesis Inc.$293
  • Musculoskeletal Transplant Foundation Inc.$147
  • Amgen$90
  • Nevro Corp.$78
  • plus $128 from 4 others

What the payments were for

  • Travel & lodging$1,93145%
  • Food & beverage$2,24353%
  • Gifts$972%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker(2 entities)34$2,579
Voom Medical Devices, Inc.2$957
Organogenesis Inc.4$293
Musculoskeletal Transplant Foundation Inc.2$147
Amgen1$90
Nevro Corp.2$78
Kerecis Limited3$70
Globus Medical1$20
Paratek Pharmaceuticals, Inc.1$19
Medtronic1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,271 in reported general payments places this provider in the 80th percentile of 59 podiatrist providers in Alabama.

See all podiatrist providers in Alabama

Medicare billing

Part B allowed, 2024
$437,216
Medicare patients
426
Services billed
3,618

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate183$3,498
Diclofenac Sodium71$2,409
Duloxetine Hcl129$1,982
Doxycycline Hyclate144$1,817
Ketoconazole69$1,709
Mupirocin190$1,507
Gentamicin Sulfate38$1,443
Gabapentin62$942
Nitro-BidNitroglycerin16$888
Terbinafine Hcl41$885
Ciclopirox25$797
Colchicine28$627
Nystatin32$575
Cephalexin94$500
Celecoxib35$488

Paid to pharmacies, not to this prescriber.

Other podiatrist in Bay Minette

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →